Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10588959 Combination vaccine

Patent 10588959 was granted and assigned to CureVac on March, 2020 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
CureVac
CureVac
0
Date Filed
February 19, 2016
0
Date of Patent
March 17, 2020
0
Patent Applicant
CureVac
CureVac
0
Patent Application Number
15048561
0
Patent Citations Received
‌
US Patent 12109275 Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded protein
0
‌
US Patent 11761009 Artificial nucleic acid molecules for improved protein expression
‌
US Patent 11786590 Rotavirus vaccines
‌
US Patent 11433139 Peptide vaccines against interleukin-31
‌
US Patent 11834651 Method for producing and purifying RNA, comprising at least one step of tangential flow filtration
0
‌
US Patent 11865084 MERS coronavirus vaccine
0
‌
US Patent 11965000 Respiratory syncytial virus (RSV) vaccine
0
‌
US Patent 12083190 Rabies vaccine
0
‌
US Patent 11661634 Method for producing RNA
0
‌
US Patent 11667910 Method for producing and purifying RNA, comprising at least one step of tangential flow filtration
0
•••
Patent Inventor Names
Margit Schnee
0
Karl-Josef Kallen
0
Thomas Kramps
0
Daniel Voss
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
10588959
0
Patent Primary Examiner
‌
Benjamin P Blumel
0

Find more entities like US Patent 10588959 Combination vaccine

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.